ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 30

Aberrant M1 Polarization of Macrophages in Behcet’s Disease

Jing Shi1, Xiuhua Wu 2, Jinjing Liu 1, Hua Chen 3 and Wenjie Zheng 1, 1Peking Union Medical College Hospital, Beijing, China (People's Republic), 2General Hospital of Tianjin Medical University, Tianjin, China (People's Republic), 3Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College; The Ministry of Education Key Laboratory, Beijing, China, Beijing, Beijing, China (People's Republic)

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Behcet's syndrome and macrophage

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Innate Immunity Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Behcet’s disease (BD) is systemic inflammatory vasculitis with unknown etiology. As a critical compartment in innate immunity, macrophages may play a role in BD. According to the phenotype and cytokine expression, macrophages can be classified into 2 subtypes, the pro-inflammatory classically activated macrophages (M1) and the anti-inflammatory alternatively activated macrophages (M2). However, the mechanism of how macrophage polarization is involved in BD is yet unidentified. Here we aim to investigate the effect of the BD serum on the phenotype and the functions of macrophages.

Methods: Thirty treatment-naïve active BD patients from our center and 30 gender- and age-matched healthy controls (HC) were included in this study. The monocytes of HC were isolated from PBMCs through CD14+ microbeads and further cultured into M0 macrophages. Then the macrophages were polarized to M1 macrophages with LPS and IFNγ, and to M2 macrophages with IL4. Serum from BD patients and HC was applied to the human monocyte-derived macrophages (HMDM). The cell surface markers and the cytokines in the supernatant were detected and compared to the phenotypes of M1 and M2 macrophages. The phagocytosis of different HMDMs was determined by the cellular uptake of Dextran. In order to investigate the effect of different HMDMs on the differentiation of Th1 and Th17 cells, HMDMs were co-cultured with naïve CD4+ T cells and the intracellular cytokines as well as the nuclear transcription factor were detected by FACS. Western-blot analysis was performed to detect the expression of JAK1, STAT1 and their phosphorylated forms in the HMDMs when stimulated with BD serum.

Results: Compared to M0 macrophages, BD serum stimulated HMDM had an increased expression of CD86 (p=0.024) and a decreased CD163 expression (p=0.009). The secretion of IL12 (p=0.019) and TNFα (p=0.0295) was also increased. The HC serum stimulated HMDM, however, had a similar phenotype with M0 macrophage. All these observations suggested BD serum could promote M1 polarization. BD serum also led to a significant increase in macrophage phagocytosis (p=0.011), which was similar with M1 phenotype (p=0.014). Moreover, M1 phenotype macrophages and BD serum treated macrophages can both promote naïve CD4+ T cells to differentiate into Th1 cells, characterized by increased IFNγ and T-bet (IFNγ: M1 p=0.037; MBD p=0.048. T-bet: M1 p=0.0009; MBD p=0.0121). No significant increase of IL17A was noted in both M1 phenotype macrophages as well as BD serum treated macrophages. After stimulating HMDM with BD serum for 5 minutes, the expressions of phosphorylated JAK1 and phosphorylated STAT1 were both elevated (pJAK1=0.0228, pSTAT1=0.0101), indicating a role if JAK1-STAT1 pathway in the BD serum treated macrophage polarization and the pathogenesis of BD.

Conclusion: Serum from patients with BD could promote M1 macrophage polarization via the JAK1-STAT1 pathway, and could also increase the macrophage phagocytosis and drive Th1 differentiation.


Disclosure: J. Shi, None; X. Wu, None; J. Liu, None; H. Chen, None; W. Zheng, None.

To cite this abstract in AMA style:

Shi J, Wu X, Liu J, Chen H, Zheng W. Aberrant M1 Polarization of Macrophages in Behcet’s Disease [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/aberrant-m1-polarization-of-macrophages-in-behcets-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/aberrant-m1-polarization-of-macrophages-in-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology